News

Deal Announcements

BrainCells Secures $20 Million More Series B Funding

Monday, April 21, 2008 5:38:00 AM PDT | VentureDeal Staff
SAN DIEGO, CA -- Pharmaceutical company BrainCells Inc. announced that it has closed its second round of financing with an additional $20 million.  The total round now stands at $50 million.

BrainCells is a drug discovery company targeting therapies for depression, related neuropsychiatric disorders and other central system diseases.

New Enterprise Associates and Alexandria Real Estate Equities participated in the additional funding, along with the company's previous investors.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1